What's new

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...

Next Article

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovi...

Related Posts

EMEA-002798-PIP04-23

EMEA-002798-PIP04-23

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Zavicefta, ceftazidime,avibactam, Date of authorisation: 23/06/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Rheumatology/Immunology Working Party

Rheumatology/Immunology Working Party

Feb 9, 2025  0